ProSolus, Inc., a subsidiary of Canoa, Inc., specializes in formulating and developing high-barrier-to-entry Transdermal Drug Delivery systems for various therapeutic categories such as pain management, cardiovascular, and neurologic care. Their state-of-the-art pharma facility in Miami, Florida, managed by a seasoned leadership team, focuses on creating sophisticated transdermal and topical patches customized to exceed expectations.
With a commitment to innovation and optimization, ProSolus collaborates with suppliers to enhance medication absorption through the skin without exotic permeation enhancers. Their experienced team offers tailored solutions for formulation, development, and manufacturing support, ensuring a seamless process from concept to completion.
Generated from the website